the staff costs didn’t go unnoticed. Almost $1M just last Q, $3M for FY. Last 5 years cumulative staff costs = $19M. Seems like you can enjoy years of comfortable and secure furlough free employment in this place... while investors bear the pain! Where do I find a job like this.
Why does the company need a president US operations, a president in EU operations and a sales and marketing director?
I’ll go with Gekkowolf’s D minus. Leadership has dodged taking tricky questions from market, last investor call was Feb 2019 which isn’t acceptable. Instead CEO sticks to friendly interviews with the likes of Dr Boreham, Finnews etc.
Agree 4C tells us nothing new, nothing on final trial results, nothing about US LAPC strategy and FDA trial.
the staff costs didn’t go unnoticed. Almost $1M just last Q, $3M...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $114.3K | 13.41M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 9972750 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 22973299 | 19 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |